I am a
Home I AM A Search Login

Papers of the Week

Papers: 13 Jan 2024 - 19 Jan 2024

2024 Jan 17

Rev Med Suisse




[Neurology: what’s new in 2023].


Pizzarotti B, Buhler-Heintze A, Allali G, Rouaud O, Bally J, Michel P, Hirt L, Théaudin M, Pot Kreis C, Ryvlin P, Sokolov A, Rossetti A, Novy J, Du Pasquier R


The year 2023 is marked by the arrival on the market of lecanemab for the treatment of Alzheimer’s disease. New biomarkers have demonstrated their usefulness in monitoring peripheral neuropathies and diagnosing synucleinopathies. A genetic study has highlighted the role of nervous system cells in the risk of progression of multiple sclerosis (MS). The adverse effects of anticonvulsant treatments after prenatal exposure and on lipid metabolism have been clarified. New anti-CGRP treatments have demonstrated their efficacy in migraine attacks and chronic migraines. The criteria for thrombectomy have been further broadened. And finally, rehabilitation is refining the management of cerebrovascular patients and those with secondary progressive MS.